Viewing Study NCT00189566

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-01-27 @ 2:07 AM
Study NCT ID: NCT00189566
Status: COMPLETED
Last Update Posted: 2011-02-25
First Post: 2005-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse
Sponsor: ARCAGY/ GINECO GROUP
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Fallopian Tube Cancer View
None Malignant Tumor of Peritoneum View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapse within 6 months View
None Previously received taxane derivative View